Related references
Note: Only part of the references are listed.Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
Jean-Francois Boileau et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
Andre Robidoux et al.
LANCET ONCOLOGY (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
Rosalinda Alvarado et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni et al.
LANCET ONCOLOGY (2012)
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Luca Gianni et al.
LANCET (2010)
Breast Cancer: Sentinel Node Identification and Classification after Neoadjuvant Chemotherapy-Systematic Review and Meta Analysis
Aine M. Kelly et al.
ACADEMIC RADIOLOGY (2009)
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French Prospective Multicentric Study
Jean-Marc Classe et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer
Samir Hidar et al.
INTERNATIONAL JOURNAL OF SURGERY (2009)
Sentinel Lymph Node Biopsy After Preoperative Chemotherapy for Breast Cancer: Findings from the Austrian Sentinel Node Study Group
Christoph Tausch et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation
P. Gimbergues et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Timing of Sentinel Lymph Node Biopsy in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
Moshe Zvi Papa et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer
Masato Hino et al.
SURGERY TODAY (2008)
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation
Erika A. Newman et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag et al.
LANCET ONCOLOGY (2007)
Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients
Seeyoun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases
Jeannie Shen et al.
CANCER (2007)
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer
Y. Xing et al.
BRITISH JOURNAL OF SURGERY (2006)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important
JL Jones et al.
AMERICAN JOURNAL OF SURGERY (2005)
Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers
DW Ollila et al.
AMERICAN JOURNAL OF SURGERY (2005)
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27
EP Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
D Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: A pilot study
T Aihara et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: Effect of clinical node status at presentation
JE Lang et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma
K Shimazu et al.
CANCER (2004)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
R Reitsamer et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
U Veronesi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Sentinel node biopsy prior to neoadjuvant chemotherapy
MS Sabel et al.
AMERICAN JOURNAL OF SURGERY (2003)
Primary chemotherapy effect in sentinel node detection in breast cancer
A Vigário et al.
CLINICAL NUCLEAR MEDICINE (2003)
Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer
GC Balch et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma
VF Cocquyt et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy
S Taucher et al.
ENDOCRINE-RELATED CANCER (2003)
Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study
JRM Piato et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer
JUN Oruwari et al.
AMERICAN JOURNAL OF SURGERY (2002)
Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma
S Krishnamurthy et al.
CANCER (2002)
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer
DN Danforth et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
The use of FISH on breast core needle samples for the presurgical assessment of HER-2 oncogene status
S Kaneko et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2002)
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer
V Stearns et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility
LA Newman et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma
AR Miller et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Utility of the tumor bed marker in patients with breast cancer receiving induction chemotherapy
P Alonso-Bartolome et al.
ACTA RADIOLOGICA (2002)
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
HM Kuerer et al.
AMERICAN JOURNAL OF SURGERY (2001)
Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer
MJ Stoutjesdijk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Review of breast MRI: Indications and limitations
EA Morris
SEMINARS IN ROENTGENOLOGY (2001)
Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme
A Fernández et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)
Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye
L Tafra et al.
ANNALS OF SURGERY (2001)
Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy
LF Baron et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2000)
Share Paper
